Effect of kollidon® sr on the release of albuterol sulphate from matrix tablets

• In: Industrial Pharmacy- Posters
• At: Istanbul (Turkey) (2009)
• Type: Poster
• Poster code: IPS-P-033
• By: SAKR, Walid (Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia)
• Co-author(s): El-Bagory, Ibrahim (Department of Pharmaceutics, College of Pharmacy, King Saud University, RIYADH, Saudi Arabia)
  Sakr, Adel (Department of Pharmaceutics, College of Pharmacy, King Saud University, RIYADH, Saudi Arabia)
  
• Abstract:

  Albuterol sulphate, an adrenergic agonist, is an effective bronchodilator drug given orally four times daily in a dose of 2-4 mg to maintain a therapeutic blood level. Albuterol sulphate has biological half-life of about 4-6 h and thus would be a good candidate for oral extended release dosage form. The objective this study was to evaluate..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login